Dual Use Research, Bioweapons and Biosecurity Iris Hunger Research Group for Biological Arms Control Carl Friedrich von Weizsäcker Centre for Science and.

Slides:



Advertisements
Similar presentations
Dual-Use Examples Lecture No. 15 Applied Version.
Advertisements

Laskjfoaisufäüaosfnöaskliruqäwej Literature CBM submissions under the Biological Weapons Convention, Germany, ,
Biodefense A Bad Idea whose Time has Come David Ozonoff, MD, MPH Boston University School of Public Health MIT Seminar series on Biosecurity Cambridge,
Regional Centers of Excellence Academic defense against bioterrorism.
P. Urbano per il Master in Medicina NBC Intervista ad Alibek EmergencyNet NEWS Service Special Report Wednesday, July 14, 1999 EmergencyNet Exclusive:
The Science of Agroterrorism Bob L. Larson, DVM, PhD, ACPVM University Extension, Commercial Agriculture Program, Beef Focus Team University of Missouri,
Bioterrorism: Changing Priorities in Medical Training and Research Richard Coico Professor and Chairman Department of Microbiology & Immunology City University.
Period 9/10 Kristen Sposetta, Aaron Mohr, Destanee Goosby, Taylor Host.
Brian J. Gorman, M.Sc., J.D. Towson University, Maryland Presentation for The National Academies’ Committee on Scientific Communication and National Security.
“The Life Sciences, Biosecurity, and Dual Use Research” Designed by: Brian Rappert Malcolm Dando University of Exeter Bradford University Marie Chevrier.
DUAL USE RESEARCH OF CONCERN US Government (USG) Policy for Institutional Oversight of Life Sciences 10/13/2014.
1 The Basic Problem: Dual-Use Research Kathryn Nixdorff Department of Microbiology and Genetics Darmstadt University of Technology, Germany.
The International Regulation of Biotechnology Lecture No. 19 Further Inf. For further information and video link please click on the right buttons in the.
What living things do you see in this picture?.
Dual-Use: The Fink Report
Draft Lecture No 14 By Malcolm Dando. I. Outline The concept of dual-use Slides The Fink Committee Report –A. Objective and structure of the report.
Risk Group and Biosafety Level. Classification of Infective Agents by Risk Group Pathogenicity Pathogenicity Infectious Dose Infectious Dose Mode of Transmission.
The International Regulation of Biotechnology Lecture No. 19.
1 Scientific Responsibility in an Age of Terrorism: Codes of Conduct for the Bioscience/medical Community Brian Rappert & Malcolm Dando.
Overview of the Lectures in the Education Module Resource Lecture No. 1.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Copyright © 2009 Pearson Education, Inc. Art and Photos in PowerPoint ® Concepts of Genetics Ninth Edition Klug, Cummings, Spencer, Palladino Chapter 24.
RS–IAP-ICSU, September 2006 NSABB National Science Advisory Board on Biosecurity Dual Use Research: Scope, Criteria and Communication.
Dual-Use Research: A Double Challenge for International Science Henry Metzger, MD Scientist Emeritus, NIAMS, NIH.
1 Biosecurity in the International Futures Programme of the OECD David B. Sawaya OECD International Futures Program Matrahaza,
Responsible Stewardship: Choices and Challenges in Preventing the Malign Use of the Life Sciences Brian Rappert.
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
SHAHID ALI Ph.D Scholar (Botany) 08-arid-954
Dual Use Research of Concern Boston University and Boston Medical Center.
Skugga Oversight Mechanisms of Research and Development in the Biological Defence Sector Addressing Future Challenges to the Biological and Toxin Weapons.
U3L2 Presentations Page 164 What to do questions What Did You Find Out questions 1 and 3.
A vaccine is biological preparation that improves immunity to a particular disease, a vaccine typically contains a disease causing micro-organisms often.
Vibrio cholerae Asiatic or Epidemic Cholera. Readings Question #1 Describe the Vibrio cholerae bacterium. Where is it found?
Dual Use Research of Concern (DURC) University of North Carolina at Greensboro.
Infectious Diseases Chapter 20, section 2. Disease is a major focus of environmental health Two categories: transmissable (or infectious) disease – can.
Vaccine Manufacturing Joe Bielitzki NanoScience Technology Center University of Central Florida Orlando, Florida
1 Biological Agents Slides will automatically advance seconds after clicking on start button.
WMD Operations Unit 6 slide 1 MODULE 2 UNIT 6 Biological.
Theoretical and methodical bases of epidemiology of extreme situations. Definition of military epidemiology.
World Health Organization Life science research: opportunities and risks for public health Ottorino Cosivi Department of Epidemic and Pandemic Alert and.
Chapter Six: Types of Modern Terrorism. Cyberterrorism.
Biological Warfare -How biology involved in human conflict-
Global Diseases biological challenges of the 21 st Century D.A. Henderson, MD, MPH Center for Biosecurity, U. of Pittsburgh Medical Center From Global.
The Integrated National Biodefense Portfolio Initiative “One-Portfolio” Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) May 6, 2009.
Royal Irish Academy Briefing Bert Rima 109/01/2016.
UNDERSTANDING BIOTERRORISM: Tara O’Toole, MD, MPH The United States Conference of Mayors Mayors Emergency, Safety & Security Summit October 24, 2001.
How can civil society play a constructive role in increasing transparency and building confidence between states parties? Iris Hunger Research Group for.
Project for Small Groups Wildlife Pathogen and Disease Surveillance Dr. Scott McBurney Wildlife Pathologist, Canadian Cooperative Wildlife Health Centre.
THE INTEGRAL ASSESSMENT OF BIOTERRORISM THREAT Episode I. Introduction Glushkov Institute of Cybernetics National Academy of Sciences of Ukraine Konstantyn.
By: David Gonzales. What is Bioterrorism?  A bioterrorism attack is the deliberate release of viruses, bacteria, toxins or other harmful agents used.
Diseases in Nature Conference John Herbold DVM, MPH, PhD, DACVPM, FACE Center for Biosecurity & Public Health Preparedness University of Texas School of.
1 The Argument for Oversight: Developments in the US John Steinbruner University of Maryland Controlling Dangerous Pathogens Project: Regional Workshop.
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
Dual Use Research of Concern
Stanford University Dual Use Research of Concern in the Life Sciences
Presentation 1 Fairen Angelin, Samson M. Sc
Ch Epidemiology Microbiology.
Higher Research Tasks Unit 4 - Immunology & Public Health
Virus DHO chapter 14.
Here is some startling information on the disease of Yellow Fever.
Review of Microbiology
Infectious Disease Vocabulary …82
Joel G. Breman, MD, DTPH Fogarty International Center
Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room  B.A. Cunha  Clinical Microbiology and Infection 
Agenda 11/20 Bioterrorism talk Bioterrorism project
Biological Agents of Warfare and Terrorism
Viruses & other Pathogens
to the USAF Air War College
VIRUSES.
RS–IAP-ICSU international workshop on science & technology developments relevant to the Biological & Toxin Weapons Convention 4 – 6 September 2006.
Presentation transcript:

Dual Use Research, Bioweapons and Biosecurity Iris Hunger Research Group for Biological Arms Control Carl Friedrich von Weizsäcker Centre for Science and Peace Research University of Hamburg, Germany International Forum on Biosecurity, Amman, October 2008

Dual Use Technology, equipment, material, or knowledge that can be used for: Peaceful or hostile Legitimate or illegitimate Beneficial or destructive purposes without, or only minor, modification.

Dual Use Activities of Concern Dual use activities whose misuse would result in particularly grave consequences. Two approaches: Based on the agents involved. Based on the results planned or achieved.

Dual Use Activities of Concern Agent Based Anthrax, hemorrhagic fevers (Ebola etc.), plague, smallpox, tularemia influenza? SARS? Genetically enhanced measles?

Dual Use Activities of Concern Result Based 1.Rendering a vaccine ineffective 2.Creating resistance to therapeutics 3.Enhancing the virulence of a pathogen 4.Rendering a nonpathogen virulent 5.Increasing transmissibility of a pathogen 6.Altering the host range of a pathogen 7.Enabling the evasion of diagnosis/detection 8.Enabling the weaponization of a biological agent or toxin Biotechnological Research in an Age of Terrorism, U.S. National Research Council, 2004.

Dual Use Activities of Concern in Biodefence Programmes Creating agents with improved bioweapons characteristics Engineering anthrax to be vaccine resistant Increasing the lethality of pox viruses Creating people knowledgable about bioweapons relevant agents Giving rise to suspicions of bioweapons development

Dual Use Activities of Concern Governance Thorough risk assessment before work is started Maximum transparency including full publication Should not be carried out in the framework of biodefence/biosecurity